- Staat
- KS
- Alter
- -
- Geschlecht
- F
- Eingang
- 03.07.2022
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Agitation
Cellulitis
Erythema
Exophthalmos
Eye movement disorder
Injection site cellulitis
Injection site erythema
Feeling abnormal
Musculoskeletal stiffness
Peripheral swelling
Pyrexia
Seizure
Injection site swelling
Symptomtext
Became stiff; Agitation; 'cellulitis' to right calf area; Very faint pinkness noted to right calf; her eyes buldged; EYE MOVEMENT DISORDER; very fussy and inconsolable; Some swelling to the R thigh; pt had a low grade fever; Eyes fluttered a little (she described this as a seizure).; This non-serious case was received from a parent and a nurse via the Vaccines Adverse Event Reporting System (VAERS) monitoring on 11-APR-2022 with the following VAERS Primary ID 2134584-1. The original narrative from the sender is available: "Mother reported that pt had a low grade fever, very fussy and inconsolable, her eyes bulged and became stiff, then her eyes fluttered a little (she described this as a seizure). Some swelling to the R thigh.". In addition: "Seen in ER. Pt put on Amoxicillin for 'cellulitis' to right calf area. Pt was visualized by this reporting nurse on 02.23.2022. Very faint pinkness noted to right calf. There was ink markings noted below knee from where medical staff outlined redness at time seen in ER."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- -
- Geschlecht
- F
- Eingang
- 03.07.2022
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Agitation
Cellulitis
Erythema
Exophthalmos
Eye movement disorder
Injection site cellulitis
Injection site erythema
Feeling abnormal
Musculoskeletal stiffness
Peripheral swelling
Pyrexia
Seizure
Injection site swelling
Symptomtext
Became stiff; Agitation; 'cellulitis' to right calf area; Very faint pinkness noted to right calf; her eyes buldged; EYE MOVEMENT DISORDER; very fussy and inconsolable; Some swelling to the R thigh; pt had a low grade fever; Eyes fluttered a little (she described this as a seizure).; This non-serious case was received from a parent and a nurse via the Vaccines Adverse Event Reporting System (VAERS) monitoring on 11-APR-2022 with the following VAERS Primary ID 2134584-1. The original narrative from the sender is available: "Mother reported that pt had a low grade fever, very fussy and inconsolable, her eyes bulged and became stiff, then her eyes fluttered a little (she described this as a seizure). Some swelling to the R thigh.". In addition: "Seen in ER. Pt put on Amoxicillin for 'cellulitis' to right calf area. Pt was visualized by this reporting nurse on 02.23.2022. Very faint pinkness noted to right calf. There was ink markings noted below knee from where medical staff outlined redness at time seen in ER."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 20.12.2021
- Impfdatum
- 16.12.2021
- Beginn
- 16.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anxiety
Crying
Depressed mood
Dizziness
Fatigue
Hypoaesthesia oral
Pallor
Paraesthesia oral
Presyncope
Stress
Symptomtext
Pt at clinic with mom for imm. Pt was to receive 7 vaccines and became upset and anxious. Mom tried to comfort pt , but he was visible stressed and crying. I asked another nurse to help as stand-by. I was able to administer the first three vaccines in pt's right arm. Pt stopped crying and laughed saying "it didn't hurt." The the pt's face got pale and he stopped laughing. He appeared close to fainting. Pt stated he felt dizzy and his tongue felt tingly or numb. Pt was not short of breath and his airway was open upon inspection. Pt appeared tired, but never lost consciousness. After giving him 5 - 10 minutes and a drink of water, he stated he was ok. After discussing the incident with pt's mom, we decided to defer the rest of the vaccines until the next week. Reviewed with mom the s x s of allergies, and that she should take him to the ER if they develop. Mom verbalized understanding.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- No prescription meds, OTC unknown
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 10,0
- Geschlecht
- F
- Eingang
- 23.11.2021
- Impfdatum
- 22.11.2021
- Beginn
- 22.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Anxiety
Bite
Fall
General physical condition abnormal
Head injury
Headache
Lip injury
Lip pain
Loss of consciousness
Neck pain
Pallor
Presyncope
Spinal X-ray
Tenderness
Symptomtext
Vaccines given today: Hep A and flu. Pt. had a vasovagal event which occurred a few minutes after receiving 2 vaccines. Mother reports that she looked dazed and then passed out falling from the exam table in a seated position to the ground hitting the left side of her head on a chair. When first seen by MA and PA, she was unconscious on the floor. PA gave called to her and gave sternal rub and she became alert. She answered questions without confusion but appeared dazed. When I entered room we layed her down on the floor, she was alert and oriented, pale and seemed dazed and anxious. We put ice packs on left side of head and neck. She complained of pain over neck, pain on left side of head and pain on lip (she had a 0.5cn laceration on lip likely from her teeth). BP 117/72, HR 85, SaO2 95%. She had tenderness to palpation over c spine. She Denied numbness or tingling in hands and feet and had full strength in hand grip and feet. Since I was unable to clear her c spine clinically, we called an ambulance for immobilization and transport to ED for further evaluation. Plan was discussed with mother
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- XR CERVICAL SPINE MAXIMUM 3 VIEWS
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- MILD INERMITTENT ASTHMA
- Andere Medikamente
- ALBUTEROL PRN
- Allergien
- NA
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 21.10.2021
- Impfdatum
- 15.10.2021
- Beginn
- 17.10.2021
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Chest X-ray
Pyrexia
Respiratory syncytial virus test
SARS-CoV-2 test
Seizure
Vomiting
Symptomtext
Patient had fever starting at night on 10/15/21, parent brought patient to ED on 10/17/21 at which time patient had 105 degree F fever and had a 20 second seizure and then vomited, ibuprofen and acetaminophen was given at ED
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- Rapid and PCR Covid test, RSV test, Chest Xray
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Slow transit constipation
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 11.10.2021
- Impfdatum
- 08.10.2021
- Beginn
- 08.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Seizure
Urinary incontinence
Symptomtext
Patient was behind on vaccines and has never had some of the vaccines, according to her shot record. This was her first dose of Hep A, Hep B, MCV4, and MMRV (she has previously had measles and rubella, but not varicella vaccine or mumps). So mother brought patient in to catch up. Vaccines were given and approximately 5 minutes after as patient was walking out, she appeared to have a seizure and wet herself. EMS was called, it was strongly suggested that mom let them take her to the ER or take her herself, but in the end mom left with her daughter and it does not appear that child was taken to the emergency room as of yet. The doctor on-call at the clinic contacted mom to encourage her to take her to the ER, but it appears that mother did not take her.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- None performed at clinic
- Aktuelle Erkrankungen
- None listed
- Vorgeschichte
- None listed
- Andere Medikamente
- No medications listed.
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 05.10.2021
- Impfdatum
- 05.10.2021
- Beginn
- 05.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood glucose increased
Hyperhidrosis
Nausea
Syncope
Vomiting
Symptomtext
Syncope, Nausea, Vomiting, diaphoretic Blood Pressure - 90/62 @ 11:30 am Blood Pressure - 104/66 @ 11:50am Blood Pressure - 93/63 @ 12:30 pm
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- Only had water earlier today: Blood Sugar - 113 Communication via language line; Mother refused EMT to be called.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 25.05.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cerebellar ataxia
Condition aggravated
Papule
Rash
Symptomtext
immediate post-12mo vaccine rash (scattered papules starting on face descending down) and acute cerebellar ataxia 1 wk later.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Chronic Lung disease Seasonal Allergic rhinitis hydronephrosis acute cerevellar ataxia perinatal IVH
- Andere Medikamente
- Cetirizine 2.5mg 1 time each day
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 22.10.2021
- Impfdatum
- 20.10.2021
- Beginn
- 21.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dyspnoea
Feeling hot
Malaise
Symptomtext
Patient's brother contacted the Dept. of Health at 10/22/21 @ 0641. He left a message stating that his sister, 'was feeling very sick, with many symptoms'. I contacted the brother, as the parents do not speak the language as their first language, he stated that the patient was at the Dept. of Health on 10/20/21 and recieved vaccinations. On 10/21/21, she began to feel warm (temperature was not taken) and intermittent periods of shortness of breath. Prior to him going to work, she was feeling a little better as their mother had given her some medications, but he did not know what their mother had given her. I contacted the patient, she stated the same, that she was feeling warm (temperature not taken) and having periods of shortness of breath. She further stated that her arms were sore. I told her that her arms could be sore from the injections that she recieved, however the temperature (?) and the shortness of breath could be COVID symptoms. I advised her to go to the emergency room as soon as possible for testing and treatment. She verbalized understanding. I called her brother back, who was at work. I told him that I spoke to his sister and that the symptoms that she was complaining of (temperature? Shortness of breath) could possibly be Covid symptoms and that because she was experiencing shortness of breath, it was advised that she goes to the emergency room as soon as possible for testing and treatment. He verbalized understanding. Unknown if patient went to the emergency room as advised or not.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Unknown
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 11.04.2022
- Impfdatum
- 10.03.2022
- Beginn
- 21.03.2022
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Burning sensation
Ear swelling
Erythema
Fatigue
Feeling hot
Inflammation
Peripheral swelling
Pruritus
Pyrexia
Urticaria
Symptomtext
3/21/2022 around 3:20 pm pt noticed redness and swelling in both hands. Both legs were itching and burning. Pt said legs felt like they were on fire. Then she noticed generalized hives all over body including face. She said her neck, face, and both ears were red. Her ears were red, swollen and hot to touch. Pt said she felt tired. She felt like she had fever but did not take her temperature. Denied swelling of lips, tongue, or throat. Denied having any SOB. Took Benadryl around 3:30 pm and all symptoms went away around 4 pm. Pt did not see a doctor for signs or symptoms. Father said they took child to ER but her symptoms were getting better so they did not stay to see the ER doctor. Pt showed me a picture of the hives on her arms and a picture of her neck and face that appeared red and inflamed. Referred pt to see her PCP regarding possible adverse reaction to vaccines. Pt received first set of childhood recommended vaccines on 3/10/2022. Father said child had not received childhood recommended vaccines before due to her brother had an anaphylaxis reaction to vaccines and nearly died. Father plans to take child to see APRN who is child's PCP.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 31.03.2022
- Impfdatum
- 31.03.2022
- Beginn
- 31.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Feeling hot
Retching
Symptomtext
Gave Hep a then HPV. After second shot patient reported feeling hot and light headed. Patient remained seated and did not lose consciousness. Open window and door, as room was hot. Patient reported he had not eaten anything. Patient had brief dry heaves. Observed patient about 15 minutes until he reported feeling ok. Patient able to leave on his own.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- -
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 1,7
- Geschlecht
- F
- Eingang
- 16.02.2022
- Impfdatum
- 15.02.2022
- Beginn
- 16.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Peripheral swelling
Urticaria
Symptomtext
swelling to both hands, swelling to both feet, hives on extremities and face
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 1,1
- Geschlecht
- F
- Eingang
- 08.02.2022
- Impfdatum
- 18.01.2022
- Beginn
- 07.02.2022
- Tage bis Beginn
- 20,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash vesicular
Symptomtext
varicella rash
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash vesicular
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- NOne
- Andere Medikamente
- none
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 1,3
- Geschlecht
- F
- Eingang
- 12.01.2022
- Impfdatum
- 14.12.2021
- Beginn
- 28.12.2021
- Tage bis Beginn
- 14,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash erythematous
Rash papular
Swelling
Symptomtext
Patient developed red, swollen, raised rash on Tuesday 12/28/21, 2 weeks after her Varicella vaccine. Parent's presented to the Clinic for concerns. Patient is well appearing and has no other symptoms. Rash does not seem to bother patient. Doctor educated parents that "1-3 percent of patients who receive varicella vaccine develop a localized rash consisting of two to five lesions at the injection site, and another 3-5 percent develop a generalized varicella-like rash within one month of immunization. Most of the vesticular rashes that occur within the first two weeks after varicella immunization are caused by wild-type VZV. People with rash should refrain from physical contact with people who are susceptible.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash erythematous
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- None
- Andere Medikamente
- Vitamin D
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 20.12.2021
- Impfdatum
- 03.12.2021
- Beginn
- 12.12.2021
- Tage bis Beginn
- 9,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Nasal congestion
Papule
Pyrexia
Rash
Rash erythematous
Symptomtext
12/12/21 fever 101.5 with nasal congestion. 12/13/21 rash noted left lateral thigh and left mid-back. erythematous area with central papule, pinpoint vesicular site. 12/14/21 fever 101.7 with two additional similar sites right facial cheek and mid-forhead.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- None
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 06.12.2021
- Impfdatum
- 15.11.2021
- Beginn
- 03.12.2021
- Tage bis Beginn
- 18,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Rash erythematous
Rash maculo-papular
Symptomtext
Red maculopapular rash appeared on abdomen 1 day after receiving vaccines. Faded without treatment after 2 weeks, but spread to both legs. On 12/3/2021 several red bumps appeared on right proximal forearm, spread to right wrist and hand within 2 days. No fever, no pain, no itching. Baby was evaluated in PCP clinic on 12/6/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- Upper respiratory infection Allergic rhinitis
- Vorgeschichte
- Recurrent ear infections, history of PE tubes
- Andere Medikamente
- Cetirizine 2.5 mg PO daily
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 19.10.2023
- Impfdatum
- 14.10.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
No adverse event
Symptomtext
0 Adverse reactions physically accured for the patient. Vaccines were given to early
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- N/A
- Allergien
- None NKDA/NKA
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 1,5
- Geschlecht
- F
- Eingang
- 03.02.2023
- Impfdatum
- 20.07.2022
- Beginn
- 20.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
accidently give Hep A too early
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- amoxicillin (AMOXIL) 400 mg/5 mL suspension
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 14.11.2022
- Impfdatum
- 11.10.2022
- Beginn
- 11.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
PATIENT WAS GIVEN PROQUAD AND WAS OLDER THAN RECOMMENDATIONS FOR THE VACCINE. NO ADVERSE EVENTS NOTED.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- nka
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 27.10.2022
- Impfdatum
- 04.03.2022
- Beginn
- 04.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Underdose
Symptomtext
received pediatric doses; received pediatric doses; received pediatric doses; received pediatric doses; This case was reported by a other health professional via call center representative and described the occurrence of underdose in a 22-year-old female patient who received HBV (Engerix B pediatric) (batch number K329E, expiry date 24th April 2023) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis, HAV (Havrix 720) (batch number 2K57N, expiry date 11th December 2022) for prophylaxis and hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 4th March 2022, the patient received Engerix B pediatric, Engerix B Pre-Filled Syringe Device, Havrix 720 and Havrix Pre-Filled Syringe Device. On 4th March 2022, unknown after receiving Engerix B pediatric and Engerix B Pre-Filled Syringe Device and not applicable after receiving Havrix 720 and Havrix Pre-Filled Syringe Device, the patient experienced underdose, adult use of a child product, underdose and adult use of a child product. On an unknown date, the outcome of the underdose, adult use of a child product, underdose and adult use of a child product were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 19-OCT-2022 Reporter's Comment: The reporter was practice manager. The reporter stated that a patient received pediatric doses of Havrix and Engerix-B. The reporter consented to follow up via postal. Additional Supportive Information: The reporter stated that, a patient received pediatric doses of Havrix and Engerix-B, which led to underdose and adult use of a child product.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 23.06.2022
- Impfdatum
- 21.02.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Administered havrix and infanrix after temperature excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a female patient who received HAV (Havrix) (batch number 2K57N, expiry date 11th December 2022) for prophylaxis. Co-suspect products included DTPa (Infanrix) (batch number 7EC55, expiry date 29th April 2023) for prophylaxis and dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 21st February 2022, the patient received the 1st dose of Havrix, the 1st dose of Infanrix and Infanrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix, Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Linked case(s) involving the same patient: US2022093643 Additional Information: GSK Receipt Date: 15-JUN-2022 Reporter's Comment: Medical assistant reported that the patient was administered the doses of Havrix and infanrix vaccines after a temperature excursion in the right arm. The reporter consented to follow-up. Additional supportive information: The patient was administered the doses of Havrix and infanrix vaccines after a temperature excursion, which led to Incorrect storage of drug. This is one of 11 cases, reported by the same reporter. The case US2022093643 was identified as duplicate of this case. The case US2022093643 was deleted and all future correspondence would be added in the present case which stands as case of record for this patient.; Sender's Comments: US-GLAXOSMITHKLINE-US2022093643:Same reporter US-GLAXOSMITHKLINE-US2022093600:Same reporter. US-GLAXOSMITHKLINE-US2022093602:Same reporter. US-GLAXOSMITHKLINE-US2022093637:Same reporter. US-GLAXOSMITHKLINE-US2022093638:Same reporter. US-GLAXOSMITHKLINE-US2022093640:Same reporter. US-GLAXOSMITHKLINE-US2022093642:Same reporter. US-GLAXOSMITHKLINE-US2022093644:Same reporter. US-GLAXOSMITHKLINE-US2022093645:Same reporter. US-GLAXOSMITHKLINE-US2022093646:Same reporter. US-GLAXOSMITHKLINE-US2022093647:Same reporter. US-GLAXOSMITHKLINE-US2022093648:Same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 1,7
- Geschlecht
- F
- Eingang
- 23.06.2022
- Impfdatum
- 10.06.2022
- Beginn
- 10.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SC / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
Symptomtext
Havrix dose administered subcutaneously instead of intramuscularly; This case was reported by a nurse via call center representative and described the occurrence of intramuscular formulation administered by other route in a 20-month-old female patient who received HAV (Havrix) (batch number 2K57N, expiry date 11th December 2022) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 10th June 2022, the patient received Havrix (subcutaneous) and Havrix Pre-Filled Syringe Device. On 10th June 2022, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 15-JUN-2022 Reporter's Comments: The patient received Havrix dose subcutaneously instead of intramuscularly. The reporter consented to follow up. The Vaccine Administration Facility was the same as Primary Reporter. Additional supportive Information: The patient received havrix subcutaneously instead of intramuscularly which led to intramuscular formulation administered by other route.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 22.06.2022
- Impfdatum
- 17.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Administered Havrix after temperature excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a female patient who received HAV (Havrix) (batch number 2K57N, expiry date 11th December 2022) for prophylaxis. On 17th March 2022, the patient received the 2nd dose of Havrix. On an unknown date, unknown after receiving Havrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. Linked case(s) involving the same patient: US2022093644 Additional Information: GSK Receipt Date: 15-JUN-2022 Reporter's comment: The medical assistant reported a patient was administered the Havrix on left arm after a temperature excursion. The reporter consented to follow up. Additional supportive information: Havrix was administered after a temperature excursion, which led to incorrect storage of vaccine. This case is one of 12 cases reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2022093597:Same reporter. US-GLAXOSMITHKLINE-US2022093643:Same reporter. US-GLAXOSMITHKLINE-US2022093602:Same reporter. US-GLAXOSMITHKLINE-US2022093637:Same reporter. US-GLAXOSMITHKLINE-US2022093638:Same reporter. US-GLAXOSMITHKLINE-US2022093640:Same reporter. US-GLAXOSMITHKLINE-US2022093642:Same reporter. US-GLAXOSMITHKLINE-US2022093644:Same reporter. US-GLAXOSMITHKLINE-US2022093645:Same reporter US-GLAXOSMITHKLINE-US2022093646:Same reporter US-GLAXOSMITHKLINE-US2022093647:Same reporter US-GLAXOSMITHKLINE-US2022093648:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 6,0
- Geschlecht
- F
- Eingang
- 21.06.2022
- Impfdatum
- 07.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Administered Havrix and Infanrix after temperature excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 6-year-old female patient who received HAV (Havrix) (batch number 2K57N, expiry date 11th December 2022) for prophylaxis. Co-suspect products included DTPa (Infanrix) (batch number 7EC55, expiry date 29th April 2023) for prophylaxis and dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 7th April 2022, the patient received Havrix and Infanrix. On an unknown date, the patient started Infanrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix, Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 15-Jun-2022 Reporter's comments: Medical assistant reported that the patient was administered with the Havrix in right arm and Infanrix in left arm after a temperature excursion. The consent to follow up was given. Additional Supportive Information: The patient was administered with the Havrix and Infanrix after a temperature excursion, which led to incorrect storage of drug. This was 1 of the 10 cases, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2022093637:Same reporter US-GLAXOSMITHKLINE-US2022093638:Same reporter. US-GLAXOSMITHKLINE-US2022093643:Same reporter. US-GLAXOSMITHKLINE-US2022093600:Same reporter. US-GLAXOSMITHKLINE-US2022093640:Same reporter. US-GLAXOSMITHKLINE-US2022093647:Same reporter. US-GLAXOSMITHKLINE-US2022093602:Same reporter. US-GLAXOSMITHKLINE-US2022093597:Same reporter. US-GLAXOSMITHKLINE-US2022093644:Same reporter. US-GLAXOSMITHKLINE-US2022093648:Same reporter. FU1 deleted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 21.06.2022
- Impfdatum
- 06.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
administered havrix after a temperature excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 1-year-old male patient who received HAV (Havrix) (batch number 2K57N, expiry date 11th December 2022) for prophylaxis. On 6th April 2022, the patient received the 1st dose of Havrix. On an unknown date, unknown after receiving Havrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. Additional Information: GSK Receipt Date: 15-Jun-2022 Reporter's comments: Medical assistant reported that the patient was administered with the Havrix vaccine after a temperature excursion in right arm. The consent to follow up was given. Additional Supportive Information: The patient was administered with the Havrix vaccine after a temperature excursion, which led to incorrect storage of drug. This was 1 of the 11 cases, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2022093643:Same reporter. US-GLAXOSMITHKLINE-US2022093637:Same reporter US-GLAXOSMITHKLINE-US2022093638:Same reporter. US-GLAXOSMITHKLINE-US2022093597:Same reporter. US-GLAXOSMITHKLINE-US2022093600:Same reporter. US-GLAXOSMITHKLINE-US2022093602:Same reporter. US-GLAXOSMITHKLINE-US2022093642:Same reporter. US-GLAXOSMITHKLINE-US2022093644:Same reporter. US-GLAXOSMITHKLINE-US2022093647:Same patient, same reporter, different product US-GLAXOSMITHKLINE-US2022093648:Same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 3,0
- Geschlecht
- M
- Eingang
- 21.06.2022
- Impfdatum
- 29.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
administered after temperature excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 3-year-old male patient who received HAV (Havrix) (batch number 2K57N, expiry date 11th December 2022) for prophylaxis. Co-suspect products included DTPa (Infanrix) (batch number 7EC55, expiry date 29th April 2023) for prophylaxis and dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 29th March 2022, the patient received the 2nd dose of Havrix, Infanrix and Infanrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix, Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 15-Jun-2022 Reporter's comments: Medical assistant reported that the patient was administered with the Havrix in left arm and Infanrix in right arm after a temperature excursion. The consent to follow up was given. Additional Supportive Information: The patient was administered with the Havrix and Infanrix after a temperature excursion, which led to incorrect storage of drug. This was 1 of the 11 cases, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2022093637:Same reporter US-GLAXOSMITHKLINE-US2022093643:Same reporter. US-GLAXOSMITHKLINE-US2022093600:Same reporter. US-GLAXOSMITHKLINE-US2022093597:Same reporter. US-GLAXOSMITHKLINE-US2022093602:Same reporter. US-GLAXOSMITHKLINE-US2022093648:Same reporter. US-GLAXOSMITHKLINE-US2022093646:Same patient - FU1 US-GLAXOSMITHKLINE-US2022093640:Same reporter. US-GLAXOSMITHKLINE-US2022093642:Same reporter. US-GLAXOSMITHKLINE-US2022093644:Same reporter. US-GLAXOSMITHKLINE-US2022093647:Same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 21.06.2022
- Impfdatum
- 29.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
administered after temperature excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a male patient who received HAV (Havrix) (batch number 2K57N, expiry date 11th December 2022) for prophylaxis. Co-suspect products included DTPa (Infanrix) (batch number 7EC55, expiry date 29th April 2023) for prophylaxis and dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 29th March 2022, the patient received the 1st dose of Havrix, the 1st dose of Infanrix and Infanrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix, Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Linked case(s) involving the same patient: US2022093645 Additional Information: GSK Receipt Date: 15-JUN-2022 Reporter's Comments: The reporter stated that, on 29th March 2022 a female patient was administered the Havrix and Infanrix vaccine after a temperature excursion. The anatomical location was left arm for Havrix and Infanrix. The reporter give consent to follow up.; Sender's Comments: US-GLAXOSMITHKLINE-US2022093643:Same reporter. US-GLAXOSMITHKLINE-US2022093600:Same reporter. US-GLAXOSMITHKLINE-US2022093597:Same reporter. US-GLAXOSMITHKLINE-US2022093602:Same reporter. US-GLAXOSMITHKLINE-US2022093645:Same reporter US-GLAXOSMITHKLINE-US2022093638:Same reporter US-GLAXOSMITHKLINE-US2022093640:Same reporter US-GLAXOSMITHKLINE-US2022093642:Same reporter US-GLAXOSMITHKLINE-US2022093644:Same reporter US-GLAXOSMITHKLINE-US2022093646:Same reporter US-GLAXOSMITHKLINE-US2022093648:Same reporter US-GLAXOSMITHKLINE-US2022093647:Same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 11.04.2022
- Impfdatum
- 11.04.2022
- Beginn
- 11.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
No adverse event
Symptomtext
Patient was given (Pediarix) when only Dtap was needed. provider called patients mother back and explained there is no adverse reactions but extra protection.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- hand foot and mouth
- Vorgeschichte
- NA
- Andere Medikamente
- tylenol
- Allergien
- NA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 1,3
- Geschlecht
- F
- Eingang
- 10.03.2022
- Impfdatum
- 09.03.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Wrong product administered
Symptomtext
pt due for Dtap and was given Hep A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- ear infection
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- -
- Geschlecht
- U
- Eingang
- 09.03.2022
- Impfdatum
- 02.03.2022
- Beginn
- 02.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Underdose
Symptomtext
adult patient received a pediatric dose of Havrix; adult patient received a pediatric dose of Havrix; This case was reported by a nurse via call center representative and described the occurrence of underdose in a adult patient who received HAV (Havrix 720) (batch number 2k57n, expiry date 22nd December 2022) for prophylaxis. On 2nd March 2022, the patient received Havrix 720. On 2nd March 2022, unknown after receiving Havrix 720, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown. Additional details reported were as follows: The age at vaccination was not reported. The adult patient received a pediatric dose of Havrix, which led to underdose and adult use of a child product. The healthcare professional could not provide patient demographics. The consent to follow up was given.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 24.02.2022
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
PEDS PFIZER VACCINE ADMINISTER TO A 14 YEAR OLD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 24.02.2022
- Impfdatum
- 23.02.2022
- Beginn
- 23.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Cough
Dysphonia
Rhinorrhoea
Stridor
Swelling face
Swelling of eyelid
Symptomtext
Significant coughing, inspiratory stridor, hoarseness, runny nose, (facial) swelling of the right upper eye lid
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cough
- Hospital-Tage
- -
- Labordaten
- No labs drawn after reaction
- Aktuelle Erkrankungen
- Positive COVID PCR test on 1/7/2022
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None Known
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 22.02.2022
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Wrong product administered
Symptomtext
Proquad was given instead of MMR vaccine. Therefore, the patient received 2 Varicella vaccines (a double dose)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- vitamin D supplement.
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 21.02.2022
- Impfdatum
- 04.02.2022
- Beginn
- 04.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Symptomtext
Mother reports no adverse reaction, re-administration of Varicella not recommended by manufacturer
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 16.02.2022
- Impfdatum
- 14.02.2022
- Beginn
- 14.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Pt received Varicella dose and Proquad dose, pt was to have MMR. Pt had no reactions, no rashes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- Zyrtec, vitamins
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- -
- Geschlecht
- F
- Eingang
- 19.01.2022
- Impfdatum
- 07.12.2021
- Beginn
- 07.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Patient received 3rd dose; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 31-month-old female patient who received HAV (Havrix) (batch number 2k57n, expiry date 11th December 2022) for prophylaxis. Previously administered products included Havrix (received first dose of Havrix on 27th April 2021, batch number CE74N and expiry date 19th June 2022). Concomitant products included HAV (Havrix). On 7th December 2021, the patient received the 3rd dose of Havrix. On 7th December 2021, unknown after receiving Havrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown. Additional details were reported as follows: Age at vaccination was unknown, however could be 30 months or 31 months at the time of vaccination. The patient received third dose of Havrix, which led to extra dose administration. Consent to follow up was granted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 1,1
- Geschlecht
- F
- Eingang
- 16.12.2021
- Impfdatum
- 23.11.2021
- Beginn
- 23.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Patient was given a 2nd Havrix Hep A after receiving one 7 wks earlier. Contacted spoke with provider, contacted Guardian (grandmother), Immunization and GSK - vaccine specialist. Was advised by employee at GSK, that the patient would need to receive another booster shot after last dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 0,2
- Geschlecht
- F
- Eingang
- 03.12.2021
- Impfdatum
- 02.12.2021
- Beginn
- 02.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
Medical Assistant mistakenly given Hep A vaccine dose to patient. The doctor ordered Hep B to be given to the patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- -
- Geschlecht
- F
- Eingang
- 26.11.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
patient got 2 doses of Havrix 7 weeks apart; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 13-month-old female patient who received HAV (Havrix) (batch number 2K57N, expiry date 4th December 2022) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Concomitant products included HAV (Havrix). On an unknown date, the patient received the 2nd dose of Havrix and Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device and an unknown time after receiving Havrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The medical assistant reported that, a pediatric patient got 2 doses of Havrix 7 weeks apart, which led to shortening of vaccinaation schedule. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- HAVRIX
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 3,0
- Geschlecht
- F
- Eingang
- 18.11.2021
- Impfdatum
- 13.10.2021
- Beginn
- 13.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Wrong product administered
Symptomtext
Pt. was given Proquad (MMRV) and she was supposed to receive Varicella only.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 12.11.2021
- Impfdatum
- 02.11.2021
- Beginn
- 02.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
Dose one on 11Jun2021, dose two 02Nov2021; This case was reported by a physician via call center representative and described the occurrence of drug dose administration interval too short in a 2-year-old female patient who received HAV (Havrix) (batch number 2K57N, expiry date unknown) for prophylaxis. Previously administered products included Havrix (received first dose on 11th June 2021). On 2nd November 2021, the patient received the 2nd dose of Havrix. On 2nd November 2021, unknown after receiving Havrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown. Additional details were provided as follows: Physician stated a patient was given dose two of Havrix earlier than recommended interval, which led to shortening of schedule. Physician was ok with follow up from safety. Expiration date of second dose was not available at time of call. No further details provided at time of call. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 12.11.2021
- Impfdatum
- 25.10.2021
- Beginn
- 25.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Underdose
Symptomtext
half of the dose administrated; This case was reported by a other health professional via call center representative and described the occurrence of accidental underdose in a 12-month-old female patient who received HAV (Havrix) (batch number 2k57n, expiry date 11th December 2022) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe (batch number 2k57n, expiry date 11th December 2022) for prophylaxis. On 25th October 2021, the patient received the 1st dose of Havrix (intramuscular) and Havrix Pre-Filled Syringe Device. On 25th October 2021, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced accidental underdose. The action taken with Havrix was unknown. On an unknown date, the outcome of the accidental underdose was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: The patient had received half of the dose of Havrix due to improper attachment of Pre-filled syringe. No further events were reported. The patient had granted consent for follow-up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 01.11.2021
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Patient was only eleven years old and received Pfizer vaccine approved for ages 12 and older.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 16.10.2021
- Impfdatum
- 11.10.2021
- Beginn
- 11.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Underdose
Symptomtext
half the dose was administered.; This case was reported by a other health professional via call center representative and described the occurrence of accidental underdose in a 12-month-old male patient who received HAV (Havrix pediatric) (batch number 2k57N, expiry date 11th December 2022) for prophylaxis. Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 11th October 2021, the patient received Havrix pediatric (intramuscular) .25 ml and Havrix Pre-Filled Syringe Device. On 11th October 2021, unknown after receiving Havrix pediatric and Havrix Pre-Filled Syringe Device, the patient experienced accidental underdose. On an unknown date, the outcome of the accidental underdose was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The HCP reported that the patient did not get complete dose of Havrix, the patient was moving and the syringe came out when administering the dose, which led to accidental underdose. The HCP stated that approximately half the dose was administered. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 7,0
- Geschlecht
- F
- Eingang
- 05.10.2021
- Impfdatum
- 30.09.2021
- Beginn
- 30.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Wrong patient received product
Symptomtext
Inadvertent administration to wrong patient. Patient was identified by mother as being her other daughter. After the vaccine was given. the nurse asked for patient and was informed by the mother that patient had received her sister's vaccine. Mother notified that the vaccine was given based an her identification of the child as well as when next dose would be due if she wanted to complete the series since the timing of the vaccine was off. Patent received her other vaccines and was observed for 20 minutes. Patient was released without any symptoms of reaction or distress. Followed up with patient's mother on 10/1. Stated that the patient was "doing fine."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKA
- Vorherige Impfungen
- -